tirzepatide vs semaglutide differences efficacy safety vs. for Weight Loss Tirzepatide vs Semaglutide 2026: 22%

Dual Agonist Therapies Fundamentally, tirzepatide and semaglutide work by mimicking natural hormones that regulate appetite and blood sugar

SURPASS2 was an openlabel, multinational, phase 3 trial and SUSTAIN FORTE was a doubleblind, multinational, phase 3b trial

Eli Lilly and Company, Grant/Award Number: N/A DATA AVAILABILITY STATEMENT Eli Lilly and Company provides access to all individual participant data collected during the trial, after anonymization, with the exception of pharmacokinetic or genetic data

But the presence of additional ingredients can affect tolerability

National Institutes of Health

Subsequent STEP trials (2 through 8) have replicated the effect across different populations and dosing schedules